Abstract
Abstract
The Trial Innovation Network has established an infrastructure for single IRB review in response to federal policies. The Network’s single IRB (sIRBs) have successfully supported over 70 multisite studies via more than 800 reliance arrangements. This has generated several lessons learned that can benefit the national clinical research enterprise, as we work to improve the conduct of clinical trials. These lessons include distinguishing the roles of the single IRB from institutional Human Research Protections programs, establishing a consistent sIRB review model, standardizing collection of local context and supplemental, study-specific information, and educating and empowering lead study teams to support their sites.
Publisher
Cambridge University Press (CUP)
Reference9 articles.
1. Local Knowledge and Single IRBs for Multisite Studies:
Challenges and Solutions
2. 7. SMART IRB Master Common Reciprocal Institutional Review Board Authorization Agreement (SMART IRB Agreement) Version 2.0. Published October 1, 2020. Available at: https://smartirb.org/assets/files/SMART_IRB_Agreement_Sample_Agreement.pdf. Accessed July 14, 2021.
3. 2. Protection of Human Subjects, 45 C.F.R. 46.
4. Public Comments on the Proposed Common Rule Mandate for Single‐IRB Review of Multisite Research
5. Resources to assist in the transition to a single IRB model for multisite clinical trials
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献